M.V.I. PEDIATRIC- ascorbic acid, retinol, ergocalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydr United States - English - NLM (National Library of Medicine)

m.v.i. pediatric- ascorbic acid, retinol, ergocalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydr

hospira, inc. - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), retinol (unii: g2sh0xkk91) (retinol - unii:g2sh0xkk91), ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), de - ascorbic acid 80 mg in 5 ml - m.v.i. pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. m.v.i. pediatric is contraindicated in patients who have: - a history of known hypersensitivity to any of the vitamins or excipients in m.v.i. pediatric [see warnings and precautions (5.2), adverse reactions (6)] - an existing hypervitaminosis the safety and effectiveness of m.v.i. pediatric for the prevention of vitamin deficiency have been established in pediatric patients up to 11 years of age receiving parenteral nutrition. the safety and effectiveness of m.v.i. pediatric have not been established in pediatric patients older than 11 years of age. m.v.i. pediatric contains aluminum that may be toxic for premature neonates. aluminum levels should be monitored periodically during administration of m.v.i. pediatric to p

VITAMEDMD ONE RX- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide United States - English - NLM (National Library of Medicine)

vitamedmd one rx- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide

vitamedmd - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1 - ascorbic acid 60 mg - vitamedmd™ one rx is a dietary supplement with dha indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. vitamedmd™ one rx can also be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with known hypersensitivity to any of the ingredients.

NATAFORT- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyrido United States - English - NLM (National Library of Medicine)

natafort- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyrido

mission pharmacal company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol acetate, dl- - unii:wr1wpi7ew8), thiamine mononitrate (unii: 8k0i04919x) (thiamine - unii:x66nso3n35), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv - ascorbic acid 120 mg - natafort® is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

TRISTART ONE- ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, riboflavin, niacin, folic acid, United States - English - NLM (National Library of Medicine)

tristart one- ascorbic acid, cholecalciferol, .alpha.-tocopherol, d-, pyridoxine hydrochloride, riboflavin, niacin, folic acid,

carwin pharmaceutical associates, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol, d- (unii: n9pr3490h9) (.alpha.-tocopherol, d- - unii:n9pr3490h9), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), iron (unii: e1uol152h7) - ascorbic acid 55 mg - tristart™ one is a dietary supplement indicated to provide vitamin, mineral and dha supplementation throughout pregnancy and in the postnatal period. tristart™ one should not be used by patients with a known history of hypersensitivity to any of the listed ingredients.

FERIVA 21 7- ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid  tablet United States - English - NLM (National Library of Medicine)

feriva 21 7- ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid tablet

avion pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), zinc glycinate (unii: 681vjx72fe) (zinc cation - unii:13s1s8sf37), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), succinic acid (unii: ab6mnq6j6l) (succinic acid - unii:ab6mnq6j6l) - ascorbic acid 175 mg

METAB- ascorbicum acidum, cysteinum, manganum gluconate, alpha-ketoglutaricum acidum, fumaricum acidum, germanium sesquioxide, i United States - English - NLM (National Library of Medicine)

metab- ascorbicum acidum, cysteinum, manganum gluconate, alpha-ketoglutaricum acidum, fumaricum acidum, germanium sesquioxide, i

apotheca company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), manganese gluconate (unii: 9yy2f980sv) (manganous cation - unii:h6ep7w5457), .alpha.-ketoglutaric acid (unii: 8id597z82x) (.alpha.-ketoglutaric acid - unii:8id597z82x), fumaric acid (unii: 88xhz13131) (fumaric acid - unii:88xhz13131), germanium sesquioxide (unii: 96we91n25t) (germanium sesquioxide - unii:96we91n25t), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), magnes - ascorbic acid 6 [hp_x] in 1 ml - indications:   for the temporary relief of symptoms related to impoverished blood and oxygenation including headache, slow metabolism, joint pain, swollen glands, sweating, congestion, low blood pressure, and fatigue. indications:   for the temporary relief of symptoms related to impoverished blood and oxygenation including headache, slow metabolism, joint pain, swollen glands, sweating, congestion, low blood pressure, and fatigue.

VP-HEME ONE- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, niacinamide, pyridoxine hydrochloride, folic acid, cyan United States - English - NLM (National Library of Medicine)

vp-heme one- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, niacinamide, pyridoxine hydrochloride, folic acid, cyan

virtus pharmaceuticals - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: - ascorbic acid 25 mg - this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

NEXA PLUS- ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine, folic acid, biotin, calcium, iron, docusate calcium, United States - English - NLM (National Library of Medicine)

nexa plus- ascorbic acid, cholecalciferol, .alpha.-tocopherol, pyridoxine, folic acid, biotin, calcium, iron, docusate calcium,

vertical pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), docusate c - ascorbic acid 28 mg - nexa® plus capsules are indicated to provide vitamin/mineral and plant-based dha supplementation throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. nexa® plus may be useful in improving the nutritional status of women prior to conception. nexa® plus capsules are contraindicated in patients with a known hypersensitivity to any of the ingredients. do not take this product if you are presently taking mineral oil, unless directed by a doctor.